Predictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: A population-based cohort study

Depression Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Nordenskjöld, Axel ^a   Von Knorring, Lars ^c   Engström, Ingemar ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867142401     PISSN: 20901321     EISSN: 2090133X     Source Type: Journal    
DOI: 10.1155/2011/470985     Document Type: Article

References (23)

1. Sobocki P., Lekander I., Borgström F., Ström O., Runeson B., The economic burden of depression in Sweden from 1997 to 2005. European Psychiatry 2007 22 3 146 152 2-s2.0-33947732650 10.1016/j.eurpsy.2006.10.006 (Pubitemid 46507737)
2. Angst J., Preisig M., Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweizer Archiv fur Neurologie und Psychiatrie 1995 146 1 5 16
3. SBU, Treatment of Depression (Behandling av Depressionssjukdomar) 2004 Stockholm, Sweden The Swedish Council on Technology Assessment in Health Care
4. Huuhka M., Korpisammal L., Haataja R., Leinonen E., One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants. Journal of ECT 2004 20 3 179 185 2-s2.0-4644363013 10.1097/00124509-200409000-00010 (Pubitemid 39281569)
5. Stoudemire A., Hill C. D., Dalton S. T., Marquardt M. G., Rehospitalization rates in older depressed adults after antidepressant and electroconvulsive therapy treatment. Journal of the American Geriatrics Society 1994 42 12 1282 1285 2-s2.0-0028052276 (Pubitemid 24377532)
6. American Psychiatric Association, Committee on Electroconvulsive Therapy., Weiner RD. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: a Task Force Report of the American Psychiatric Association 2001 2nd Washington, DC, USA American Psychiatric Association
7. Sackeim H. A., Haskett R. F., Mulsant B. H., Thase M. E., Mann J. J., Pettinati H. M., Greenberg R. M., Crowe R. R., Cooper T. B., Prudic J., Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001 285 10 1299 1307 2-s2.0-0035857786 (Pubitemid 32216144)
8. Kellner C. H., Knapp R. G., Petrides G., Rummans T. A., Husain M. M., Rasmussen K., Mueller M., Bernstein H. J., O'Connor K., Smith G., Biggs M., Bailine S. H., Malur C., Yim E., McClintock S., Sampson S., Fink M., Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the consortium for research in electroconvulsive therapy (CORE). Archives of General Psychiatry 2006 63 12 1337 1344 2-s2.0-33845324512 10.1001/archpsyc.63.12.1337 (Pubitemid 44878518)
9. Tew J. D. Jr., Mulsant B. H., Haskett R. F., Joan P., Begley A. E., Sackeim H. A., Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. Annals of Clinical Psychiatry 2007 19 1 1 4 2-s2.0-33947312847 10.1080/10401230601163360 (Pubitemid 46439716)
10. Andrade C., Nelson A. I., Fink M., ECT in the management of major depression: implications of recent research. The World Journal of Biological Psychiatry 2003 4 3 139 140 2-s2.0-0642366845
11. Komossa K., Depping A. M., Gaudchau A., Kissling W., Leucht S., Second-generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database of Systematic Reviews 2010 12 CD008121
12. Chen J., Gao K., Kemp D. E., Second-generation antipsychotics in major depressive disorder: update and clinical perspective. Current Opinion in Psychiatry 2011 24 1 10 17 2-s2.0-78650569849 10.1097/YCO.0b013e3283413505
13. Ten Doesschate M. C., Bockting C. L. H., Koeter M. W. J., Schene A. H., Prediction of recurrence in recurrent depression: a 5.5-year prospective study. Journal of Clinical Psychiatry 2010 71 8 984 991 2-s2.0-77955995039 10.4088/JCP.08m04858blu
14. Sackeim H. A., Prudic J., Devanand D. P., Decina P., Kerr B., Malitz S., The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. Journal of Clinical Psychopharmacology 1990 10 2 96 104 2-s2.0-0025215518 (Pubitemid 20137605)
15. Nierenberg A. A., Husain M. M., Trivedi M. H., Fava M., Warden D., Wisniewski S. R., Miyahara S., Rush A. J., Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR-D report. Psychological Medicine 2010 40 1 41 50 2-s2.0-76649089932 10.1017/ S0033291709006011
16. Davis L. L., Wisniewski S. R., Howland R. H., Trivedi M. H., Husain M. M., Fava M., McGrath P. J., Balasubramani G. K., Warden D., Rush A. J., Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR-D level one treatment outcomes. Drug and Alcohol Dependence 2010 107 2-3 161 170 2-s2.0-77649187826 10.1016/j.drugalcdep. 2009.10.003
17. Howland R. H., John Rush A., Wisniewski S. R., Trivedi M. H., Warden D., Fava M., Davis L. L., Balasubramani G. K., McGrath P. J., Berman S. R., Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug and Alcohol Dependence 2009 99 1-3 248 260 2-s2.0-57049107321 10.1016/j.drugalcdep.2008.08. 010
18. McGrath P. J., Stewart J. W., Quitkin F. M., Chen Y., Alpert J. E., Nierenberg A. A., Fava M., Cheng J., Petkova E., Predictors of relapse in a prospective study of fluoxetine treatment of major depression. American Journal of Psychiatry 2006 163 9 1542 1548 2-s2.0-33749075174 10.1176/appi.ajp.163.9. 1542 (Pubitemid 44465753)
19. Guy W., ECDEU Assessment Manual for Psychopharmacology 1976 Rockville, Md, USA National Institute of Health, Psychopharmacology Research Branch
20. Svanborg P., Åsberg M., A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Åsberg Depression Rating Scale (MADRS). Journal of Affective Disorders 2001 64 2-3 203 216 2-s2.0-0035059659 10.1016/S0165-0327(00)00242-1 (Pubitemid 32324213)
21. Sackeim H. A., Dillingham E. M., Prudic J., Cooper T., McCall W. V., Rosenquist P., Isenberg K., Garcia K., Mulsant B. H., Haskett R. F., Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Archives of General Psychiatry 2009 66 7 729 737 2-s2.0-67650446544 10.1001/archgenpsychiatry.2009.75
22. Nelson J. C., Papakostas G. I., Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. American Journal of Psychiatry 2009 166 9 980 991 2-s2.0-69949087539 10.1176/appi.ajp.2009.09030312
23. Dhondt T. D., Beekman A. T. F., Deeg D. J., van Tilburg W., Iatrogenic depression in the elderly. Results from a community-based study in the Netherlands. Social Psychiatry and Psychiatric Epidemiology 2002 37 8 393 398 2-s2.0-0036952797 10.1007/s00127-002-0573-4 (Pubitemid 36097277)